We discussed how Aurora Cannabis and Canopy Growth are preparing for the second phase of legalization. To learn more, read Cannabis 2.0: Aurora Cannabis Gears Up for Edibles Market and Canopy Growth: Getting Ready for Cannabis 2.0.

Meanwhile, to give Aphria competition in the vaping segment, Canopy Growth made a distribution agreement with Greenlane Holdings. Notably, Greenlane will distribute Canopy Growth’s vaporizer products from its Storz & Bickel vaporizer business in the US. OrganiGram (OGI) will also be manufacturing vape pen products through its new facility.

In September, Aurora Cannabis fell 20.1%, while Canopy Growth fell 2.7%. OrganiGram fell 18.2%, while Aphria fell 17.0% in September.

While cannabis companies prepare for the edibles and vapes market, vaping-related deaths are a significant concern in the US.

We’ll have to see how cannabis companies can play out their expansion plans. Will they be able to cash in from the edibles market and improve their profitability?

Meanwhile, many other factors are taking the cannabis sector for a ride this year. Read Cannabis Stocks: Will Tough Times End Soon? to learn more.

Stay with us for the latest updates on the cannabis sector.